$SIBN

DUNN JEFFREY W sold $369K of SIBN

DUNN JEFFREY W sold 20,000 shares of SI-BONE, Inc. (SIBN) at $18.46 ($0.37M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUNN JEFFREY W
Published Aug 5, 2026, 10:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 11:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SIBN
Neutral
medium confidence
Mentioned
$SIBN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

The disclosed fact is the size, price, and timing of the director’s open-market sale, plus confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 framing reduces the likelihood of a fundamental signal.

03

What to watch

The article does not state whether there were concurrent purchases, option exercises, or other insider activity around the same period, which could change interpretation.

Relevance 3/10Novelty 3/10Timing: Form 4 filed Aug 5, covering an Aug 3 sale.

Background

The article is a SEC Form 4 insider transaction disclosure for SI-BONE, Inc., reported by a director.

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

SI-BONE director Jeffrey W Dunn sold 20,000 shares in an open-market transaction on Aug 3 at $18.4607, per Form 4 filed Aug 5.

Expected impact

Likely limited immediate price impact; any effect would be sentiment-driven and should fade unless accompanied by other news.

Evidence & confidence

The filing is a routine Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed in the text.

Market effects

No sector-level implications are provided; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • SI-BONE, Inc.

    Company whose director insider sale is disclosed in the Form 4.

  • DUNN JEFFREY W

    Director who sold 20,000 shares on Aug 3 under an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to t